Die ambulant erworbene Pneumonie geht vor allem bei intensivmedizinischer Behandlungsnotwendigkeit mit einer hohen Letalität einher. Risikoscores helfen bei der Schweregradabschätzung und ermöglichen Ihnen, die richtige Therapieentscheidung zu treffen.
Literatur
Ewig S, Höffken G, Kern WV et al. Behandlung von erwachsenen Patienten mit ambulant erworbener Pneumonie und Prävention — Update 2016. Pneumologie (Stuttgart, Germany) 2016; 70(3): 151–200
Ewig S, Birkner N, Strauss R et al. New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality. Thorax 2009; 64(12): 1062–1069
Cilloniz C, Ferrer M, Liapikou A et al. Acute respiratory distress syndrome in mechanically ventilated patients with communityacquired pneumonia. The European respiratory journal 2018; 51(3)
Ieven M, Coenen S, Loens K et al. Aetiology of lower respiratory tract infection in adults in primary care: a prospective study in 11 European countries. Clinical microbiology and infection the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2018; 24(11): 1158–1163
Ramirez JA, Wiemken TL, Peyrani P et al. Adults Hospitalized With Pneumonia in the United States: Incidence, Epidemiology, and Mortality. Clinical infectious diseases an official publication of the Infectious Diseases Society of America 2017; 65(11): 1806–1812
Braeken DCW, Franssen FME, Baum H von et al. Bacterial aetiology and mortality in COPD patients with CAP: results from the German Competence Network, CAPNETZ. int j tuberc lung dis 2017; 21(2): 236–243
McCullers JA. The co-pathogenesis of influenza viruses with bacteria in the lung. Nature reviews. Microbiology 2014; 12(4): 252–262
Alimi Y, Lim WS, Lansbury L et al. Systematic review of respiratory viral pathogens identified in adults with community-acquired pneumonia in Europe. Journal of clinical virology the official publication of the Pan American Society for Clinical Virology 2017; 95: 26–35
Bewick T, Greenwood S, Lim WS. The impact of an early chest radiograph on outcome in patients hospitalised with community-acquired pneumonia. Clinical Medicine 2010; 10(6): 563–567
Reissig A, Copetti R, Mathis G et al. Lung ultrasound in the diagnosis and follow-up of community-acquired pneumonia: a prospective, multicenter, diagnostic accuracy study. Chest 2012; 142(4): 965–972
Bauer TT, Ewig S, Marre R et al. CRB-65 predicts death from community-acquired pneumonia. Journal of internal medicine 2006; 260(1): 93–101
Ewig S, Bauer T, Richter K et al. Prediction of in-hospital death from community-acquired pneumonia by varying CRB-age groups. The European respiratory journal 2013; 41(4): 917–922
Kolditz M, Ewig S, Schütte H et al. Assessment of oxygenation and comorbidities improves outcome prediction in patients with community-acquired pneumonia with a low CRB-65 score. Journal of internal medicine 2015; 278(2): 193–202
Zhou H, Lan T, Guo S. Stratified and prognostic value of admission lactate and severity scores in patients with community-acquired pneumonia in emergency department: A single-center retrospective cohort study. Medicine 2019; 98(41): e17479
Levy MM, Evans LE, Rhodes A. The Surviving Sepsis Campaign Bundle: 2018 update. Intensive care medicine 2018; 44(6): 925–928
Pletz MWR, McGee L, Burkhardt O et al. Ciprofloxacin treatment failure in a patient with resistant Streptococcus pneumoniae infection following prior ciprofloxacin therapy. European journal of clinical microbiology & infectious diseases official publication of the European Society of Clinical Microbiology 2005; 24(1): 58–60
Rosón B, Carratalà J, Verdaguer R et al. Prospective study of the usefulness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization. Clinical infectious diseases an official publication of the Infectious Diseases Society of America 2000; 31(4): 869–874
Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax 2012; 67(1): 71–79
Garin N, Genné D, Carballo S et al. ß-Lactam monotherapy vs ß-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial. JAMA internal medicine 2014; 174(12): 1894–1901
Ceccato A, Cilloniz C, Martin-Loeches I et al. Effect of Combined ß-Lactam/Macrolide Therapy on Mortality According to the Microbial Etiology and Inflammatory Status of Patients With Community-Acquired Pneumonia. Chest 2019; 155(4): 795–804
Louie JK, Yang S, Acosta M et al. Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09. Clinical infectious diseases an official publication of the Infectious Diseases Society of America 2012; 55(9): 1198–1204
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Grünewaldt, A., Hügel, C., Bellinghausen, C. et al. Letalität der ambulant erworbenen Pneumonie nicht unterschätzen!. MMW - Fortschritte der Medizin 162, 39–42 (2020). https://doi.org/10.1007/s15006-020-0216-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15006-020-0216-2